PMC4789043_01
((a) and (b)) Comparison of AKI severity, using RIFLE criteria, between Group A and Group B patients. ((c) and (d)) Comparison of AKI severity, using AKIN criteria, between Group A and Group B patients.
CRP2016-3708210.002.jpg
PMC4789043_01_CRP2016-3708210.002.jpg
fig2
In these subjects, as in those with AKI, therapy was tailored to minimize the risk of renal complication (Figures 2(b) and 2(d)).